MCNA Bladder cancer treatment......
I never hear anyone on this board discuss the potential residual value the MCNA Bladder cancer technology for Humans may have after it was "put on the shelf" by Prometic Life Sciences (now LMNL) back in 2016. MCNA was "shelved" because the FDA required an additional Phase 3 (B) trial with a larger number of participants and that would add another 3 to 4 years of money and study before granting approval. Bioniche/Telesta's spent 100's of millions of dollars on this technology attaining a Phase 3 (A) review by the FDA advisary committee back in 2015. The FDA review comittee did not recommend by a 18 (no) and 6 (yes) vote with most Urologist on the panel voting yes.
https://www.biospace.com/article/releases/fda-panel-rejects-telesta-s-bladder-cancer-drug-mcna-/
Interesting how this technology just sits on the shelf hidden away somewhere and never discussed or brought up after Prometic Life Sciences morphed into LMNL. I've never heard a word about it for years. It's also interesting how this technology is working with former CEO of Bioniche, Graeme McRae's new company NovaVive in animal cancers.
https://www.novavive.ca/assets/files/NovaVive%20Corporate%20Overview-08.21.pdf